(13Z)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-20-methyl-11-oxa-3,5,18,22-tetrazatricyclo[18.2.1.04,9]tricosa-4(9),5,7,13-tetraene-2,17-dione

C35H37BrN8O5 — CID 170189241

IUPAC(13Z)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-20-methyl-11-oxa-3,5,18,22-tetrazatricyclo[18.2.1.04,9]tricosa-4(9),5,7,13-tetraene-2,17-dione
SMILESCC(=O)c1nn(CC(=O)N2CC3(C)CNC(=O)CC/C=C\COCc4ccc(Br)nc4NC(=O)C2C3)c2ccc(-c3cnc(C)nc3)cc12
InChIInChI=1S/C35H37BrN8O5/c1-21(45)32-26-13-23(25-15-37-22(2)38-16-25)8-10-27(26)44(42-32)17-31(47)43-20-35(3)14-28(43)34(48)41-33-24(9-11-29(36)40-33)18-49-12-6-4-5-7-30(46)39-19-35/h4,6,8-11,13,15-16,28H,5,7,12,14,17-20H2,1-3H3,(H,39,46)(H,40,41,48)/b6-4-
InChIKeyQOEWFOJLLJRNAI-XQRVVYSFSA-N
MW729.64 g/mol
LogP4.39
Rot. Bonds4

About (13Z)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-20-methyl-11-oxa-3,5,18,22-tetrazatricyclo[18.2.1.04,9]tricosa-4(9),5,7,13-tetraene-2,17-dione

(13Z)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-20-methyl-11-oxa-3,5,18,22-tetrazatricyclo[18.2.1.04,9]tricosa-4(9),5,7,13-tetraene-2,17-dione (PubChem CID 170189241) has the molecular formula C35H37BrN8O5 and a molecular weight of 729.64 g/mol. Its IUPAC name is (13Z)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-20-methyl-11-oxa-3,5,18,22-tetrazatricyclo[18.2.1.04,9]tricosa-4(9),5,7,13-tetraene-2,17-dione.

Molecular Properties

Compound Name(13Z)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-20-methyl-11-oxa-3,5,18,22-tetrazatricyclo[18.2.1.04,9]tricosa-4(9),5,7,13-tetraene-2,17-dione
PubChem CID170189241
Molecular FormulaC35H37BrN8O5
Molecular Weight729.64 g/mol
Exact Mass728.21
IUPAC Name(13Z)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-20-methyl-11-oxa-3,5,18,22-tetrazatricyclo[18.2.1.04,9]tricosa-4(9),5,7,13-tetraene-2,17-dione
SMILESCC(=O)c1nn(CC(=O)N2CC3(C)CNC(=O)CC/C=C\COCc4ccc(Br)nc4NC(=O)C2C3)c2ccc(-c3cnc(C)nc3)cc12
InChIInChI=1S/C35H37BrN8O5/c1-21(45)32-26-13-23(25-15-37-22(2)38-16-25)8-10-27(26)44(42-32)17-31(47)43-20-35(3)14-28(43)34(48)41-33-24(9-11-29(36)40-33)18-49-12-6-4-5-7-30(46)39-19-35/h4,6,8-11,13,15-16,28H,5,7,12,14,17-20H2,1-3H3,(H,39,46)(H,40,41,48)/b6-4-
InChIKeyQOEWFOJLLJRNAI-XQRVVYSFSA-N
XLogP4.39
TPSA161.30 Ų
H-Bond Donors2
H-Bond Acceptors10
Rotatable Bonds4
Heavy Atoms49
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500729.64
LogP ≤ 54.39
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (13Z)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-20-methyl-11-oxa-3,5,18,22-tetrazatricyclo[18.2.1.04,9]tricosa-4(9),5,7,13-tetraene-2,17-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (13Z)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-20-methyl-11-oxa-3,5,18,22-tetrazatricyclo[18.2.1.04,9]tricosa-4(9),5,7,13-tetraene-2,17-dione?
The IUPAC name of (13Z)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-20-methyl-11-oxa-3,5,18,22-tetrazatricyclo[18.2.1.04,9]tricosa-4(9),5,7,13-tetraene-2,17-dione (CID 170189241) is (13Z)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-20-methyl-11-oxa-3,5,18,22-tetrazatricyclo[18.2.1.04,9]tricosa-4(9),5,7,13-tetraene-2,17-dione.
What is the SMILES notation for (13Z)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-20-methyl-11-oxa-3,5,18,22-tetrazatricyclo[18.2.1.04,9]tricosa-4(9),5,7,13-tetraene-2,17-dione?
The canonical SMILES for (13Z)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-20-methyl-11-oxa-3,5,18,22-tetrazatricyclo[18.2.1.04,9]tricosa-4(9),5,7,13-tetraene-2,17-dione is CC(=O)c1nn(CC(=O)N2CC3(C)CNC(=O)CC/C=C\COCc4ccc(Br)nc4NC(=O)C2C3)c2ccc(-c3cnc(C)nc3)cc12.
What is the InChIKey of (13Z)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-20-methyl-11-oxa-3,5,18,22-tetrazatricyclo[18.2.1.04,9]tricosa-4(9),5,7,13-tetraene-2,17-dione?
The InChIKey is QOEWFOJLLJRNAI-XQRVVYSFSA-N. The full InChI is InChI=1S/C35H37BrN8O5/c1-21(45)32-26-13-23(25-15-37-22(2)38-16-25)8-10-27(26)44(42-32)17-31(47)43-20-35(3)14-28(43)34(48)41-33-24(9-11-29(36)40-33)18-49-12-6-4-5-7-30(46)39-19-35/h4,6,8-11,13,15-16,28H,5,7,12,14,17-20H2,1-3H3,(H,39,46)(H,40,41,48)/b6-4-.
What are the key properties of (13Z)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-20-methyl-11-oxa-3,5,18,22-tetrazatricyclo[18.2.1.04,9]tricosa-4(9),5,7,13-tetraene-2,17-dione?
(13Z)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-20-methyl-11-oxa-3,5,18,22-tetrazatricyclo[18.2.1.04,9]tricosa-4(9),5,7,13-tetraene-2,17-dione has a molecular weight of 729.64 g/mol, XLogP of 4.39, 4 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for (13Z)-22-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-6-bromo-20-methyl-11-oxa-3,5,18,22-tetrazatricyclo[18.2.1.04,9]tricosa-4(9),5,7,13-tetraene-2,17-dione is sourced from PubChem (CID 170189241), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).